Publications
5674 Results
- Journal / Conference
- ASCO
- Year
- 1974
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-7200
Methyl CCNU in Hodgkin's disease and other tumors
- Journal / Conference
- ASH
- Year
- 1974
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-7204/7205
Hydroxyldaunomycin (adriamycin) combination chemo- therapy for advanced non-Hodgkin's lymphoma
- Journal / Conference
- Cancer Res 34(2):392-397
- Year
- 1974
- Research Committee(s)
- Leukemia
Pharmacokinetics of 1-beta-D-arabinoforanosylcytosine in humans.
- Journal / Conference
- Cancer Chemotherapy Reports 57:465-471
- Year
- 1974
Clinical evaluation of toxic effects of cisdiammine- dichloroplatinum (NSC-119875) - Phase I clinical study.
- Journal / Conference
- Cancer Chemotherapy Reports 58:683-688
- Year
- 1974
- Research Committee(s)
- Brain
Drug trials in neuroblastoma: cyclophosphamide (NSC- 26271) versus vincristine (NSC-67574) and cyclophos- phamide, 6MP (NSC-755) gMMPR (NSC-40774), cytosine arabinoside (NSC-63878).
- Journal / Conference
- Cancer Chemotherapy Reports 58:719-722
- Year
- 1974
Response of childhood histiocytosis X to procarbazine.
- Journal / Conference
- ASCO (#737)
- Year
- 1974
- Study Number(s)
- SWOG-7206
Dose response evaluation of adriamycin.
- Journal / Conference
- AACR 15:121 (#484)
- Year
- 1974
- Study Number(s)
- SWOG-7208
A phase II study of 5-azacytidine (5-azaC) in the treatment of solid tumors.
- Journal / Conference
- Biochem Pharmacol 2:183-192
- Year
- 1974
- Research Committee(s)
- Sarcoma
- Study Number(s)
- SWOG-7210
Chemotherapy of metastatic sarcomas using combinations with adriamycin.
- Journal / Conference
- Cancer Chemotherapy Reports 58:265- 270
- Year
- 1974
- Research Committee(s)
- Sarcoma
- Study Number(s)
- SWOG-7210